[1]Liang-Hong Wu,Liang-Chuan Wu.Computer Simulation Based Chemical Patent Value[J].信息化理论与实践,2016,(01):2-10.
点击复制

Computer Simulation Based Chemical Patent Value()
分享到：

《信息化理论与实践》[ISSN:2520-5862/CN:]

卷:
期数:
2016年01期
页码:
2-10
栏目:
理論研究
出版日期:
2016-12-31

文章信息/Info

作者:
Liang-Hong Wu; Liang-Chuan Wu
Business School, University of Shanghai for Science and Technology, Shanghai 200093, China Institute of Technology Management, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan R.O.C.
关键词:
Chemical Patent Value;  Computer Simulation;  Dynamic
摘要:
Chemical patent evaluation is a growing concern in industrial and academic research. Patent value conventionally considered a constant. However, the unique characteristics of changing patent value in its life cycle must be considered. This study proposes a simulation model of chemical patent value. Additionally, comparative parameter analyses are conducted to provide detailed information for the proposed model. The analytical results show that drift rate and volatility positively affect patent value. In contrast with the traditional view of patent value as a constant, the proposed model is more realistic for patent evaluation and captures more realistic patent value.

参考文献/References:

Arojarvi, O. (2001). "How to value biotechnology firms: A study of current approaches and key value drivers." Master's Thesis in Finance Theory, Helsinki School of Economics and Business Administration. Baudry, M. and B. Dumont (2006). "Patent Renewals as Options: Improving the mechanism for weeding out lousy patents." Review of Industrial Organization 28(1): 41-62. Business-Insights. (2006). "Pharmaceutical Licensing Strategies." from http://www.globalbusinessinsights.com/content/rbhc0161m.pdf. Datamonitor. (2005). "Licensing Strategies: Trends in the top 20 pharmaceutical companies' activity." from http://www.the-infoshop.com/report/dc33659-licensing-pharma.html. Dias, M. A. G. (2001). Selection of alternatives of investment in information for oil-field development using evolutionary real options approach, Citeseer. Dixit, A. (1995). "Irreversible Investment with Uncertainty and Scale Economies." Journal of Economic Dynamics & Control 19(1-2): 327-350. Dixit, A. and R. S. Pindyck (1994). Investment under Uncertainty. NJ, Princeton University Press. Dixit, A. K. and R. S. Pindyck (1994). Investment under uncertainty, Princeton University Press. Gatyas, G. and C. Savage. (2010). "IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually through 2014; Maintains Expectations of 4-6% Growth in 2010." from http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d 88f611019418c22a/?vgnextoid=4b8c410b6c718210VgnVCM100000ed152ca 2RCRD&vgnextchannel=41a67900b55a5110VgnVCM10000071812ca2RCR D&vgnextfmt=default. Kellogg, D. and J. M. Charnes (2000). "Real-Options Valuation for a Biotechnology Company." Financial Analysts Journal 56(3): 76-84. Kulatilaka, N. and E. C. Perotti (1998). "Strategic growth options." Management Science 44(8): 1021-1031. MOEA (2008). The Biotechnology and Pharmaceutical Industries Program Office. MOEA. Myers, S. C. (1974). "Interactions of corporate finance and investment decisions—implications for capital budgeting." Journal of Finance 29(1): 1-25. Myers, S. C. and C. D. Howe (1997). "A life-cycle financial model of pharmaceutical R&D." Program on the Pharmaceutical Industry, Massachusetts Institute of Technology. Pindyck, R. S. (1988). "Irreversible Investment, Capacity Choice, and the Value of the Firm." American Economic Review 78(5): 969-985. Schwartz, E. S. (2004). "Patents and R&D as real options." Economic Notes 33(1): 23-54. Schwartz, E. S. and M. Moon (2000). "Rational pricing of Internet companies." Financial Analysts Journal 56(3): 62-75. Trigeorgis, L. (1993). "The Nature of Option Interactions and the Valuation of Investments with Multiple Real Options." Journal of Financial and Quantitative Analysis 28(1): 1-20. Villiger, R. and B. Bogdan (2005). "Getting real about valuations in biotech." Nature Biotechnology 23(4): 423-428. Wu, L. and L. Wu (2011). "Pharmaceutical patent evaluation and licensing using a stochastic model and Monte Carlo simulations." Nature biotechnology 29(9): 798-801. Wu, M. C. and C. Y. Tseng (2006). "Valuation of patent–a real options perspective." Applied Economics Letters 13(5): 313-318.

更新日期/Last Update: 2016-06-30